After adding several new businesses and products through acquisitions over the last couple of years, Invitrogen is now considering selling off or discontinuing some 'minor' yet undisclosed product lines or business units, the firm said this week.

The firm is not disclosing which products or businesses are being considered for divestiture, and a company spokesperson told BioCommerce Week that the process is the natural result of integrating many pieces into the company over the past two years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.